These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20033219

  • 21. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 22. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [Abstract] [Full Text] [Related]

  • 23. Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.
    Gipson DS, Trachtman H, Kaskel FJ, Radeva MK, Gassman J, Greene TH, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Middleton JP, Vehaskari VM, Hogan SL, Vento S, Flynn PA, Powell LM, McMahan JL, Siegel N, Friedman AL.
    Kidney Int; 2011 Mar; 79(6):678-685. PubMed ID: 21178977
    [Abstract] [Full Text] [Related]

  • 24. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis.
    Buyukcelik M, Cengiz N, Dursun H, Soran M, Bayazit AK, Noyan A, Anarat A.
    Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836
    [Abstract] [Full Text] [Related]

  • 25. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 26. Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.
    Ghiggeri GM, Musante L, Candiano G, Bruschi M, Santucci L, Barbano G, Trivelli A, Rivabella L, Gusmano R, Perfumo F.
    Pediatr Nephrol; 2007 Nov; 22(11):1953-6. PubMed ID: 17661091
    [Abstract] [Full Text] [Related]

  • 27. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone.
    Waldo FB, Benfield MR, Kohaut EC.
    Pediatr Nephrol; 1998 Jun; 12(5):397-400. PubMed ID: 9686959
    [Abstract] [Full Text] [Related]

  • 28. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
    Dęborska-Materkowska D, Kozińska-Przybył O, Mikaszewska-Sokolewicz M, Durlik M.
    Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
    [Abstract] [Full Text] [Related]

  • 29. A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.
    Lieberman KV, Tejani A.
    J Am Soc Nephrol; 1996 Jan; 7(1):56-63. PubMed ID: 8808110
    [Abstract] [Full Text] [Related]

  • 30. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
    Shishido S, Satou H, Muramatsu M, Hamasaki Y, Ishikura K, Hataya H, Honda M, Asanuma H, Aikawa A.
    Clin Transplant; 2013 Jan; 27(2):E143-50. PubMed ID: 23383697
    [Abstract] [Full Text] [Related]

  • 31. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab.
    Marasà M, Cravedi P, Ruggiero B, Ruggenenti P.
    BMJ Case Rep; 2014 Aug 25; 2014():. PubMed ID: 25155494
    [Abstract] [Full Text] [Related]

  • 32. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 25; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 33. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis.
    Jayaraman VK, Thomas M.
    BMJ Case Rep; 2016 Feb 17; 2016():. PubMed ID: 26887886
    [Abstract] [Full Text] [Related]

  • 34. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS, Sorof JM, Brewer ED, Kale AS.
    Am J Kidney Dis; 2001 Oct 17; 38(4):754-60. PubMed ID: 11576878
    [Abstract] [Full Text] [Related]

  • 35. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M, Tomiyoshi Y, Kishi T, Ikeda Y, Sakemi T, Sanai T, Node K.
    Ther Apher Dial; 2008 Aug 17; 12(4):333-6. PubMed ID: 18789122
    [Abstract] [Full Text] [Related]

  • 36. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Aug 17; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 37. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N, Ozaltin F, Emre S, Anarat A, Alpay H, Bakkaloğlu A, Baskin E, Buyan N, Dönmez O, Düşünsel R, Ekim M, Göko F, Gür-Güven A, Kavukçu S, Mir S, Sönmez F.
    Turk J Pediatr; 2010 Aug 17; 52(3):255-61. PubMed ID: 20718182
    [Abstract] [Full Text] [Related]

  • 38. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
    Tatangelo P, Londrino F, Di Vasta G, Guido G, Centi A, Dominijanni S, Bernabei E, Caramiello MS, Di Franco D, Palumbo R.
    G Ital Nefrol; 2018 May 17; 35(3):. PubMed ID: 29786187
    [Abstract] [Full Text] [Related]

  • 39. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
    Kumar J, Shatat IF, Skversky AL, Woroniecki RP, Del Rio M, Perelstein EM, Johnson VL, Mahesh S.
    Pediatr Nephrol; 2013 Feb 17; 28(2):333-8. PubMed ID: 23052653
    [Abstract] [Full Text] [Related]

  • 40. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
    Yabu JM, Ho B, Scandling JD, Vincenti F.
    Am J Transplant; 2008 Jan 17; 8(1):222-7. PubMed ID: 17979998
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.